Clover Health Investments (CLOV) Enterprise Value (2019 - 2025)
Clover Health Investments (CLOV) has disclosed Enterprise Value for 7 consecutive years, with -$101.4 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 47.87% year-over-year to -$101.4 million, compared with a TTM value of -$101.4 million through Dec 2025, up 47.87%, and an annual FY2025 reading of -$101.4 million, up 47.87% over the prior year.
- Enterprise Value was -$101.4 million for Q4 2025 at Clover Health Investments, up from -$191.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$101.4 million in Q4 2025 and bottomed at -$586.2 million in Q2 2021.
- Average Enterprise Value over 5 years is -$285.3 million, with a median of -$289.2 million recorded in 2022.
- The sharpest move saw Enterprise Value tumbled 166791.0% in 2021, then surged 55.76% in 2023.
- Year by year, Enterprise Value stood at -$317.2 million in 2021, then grew by 7.54% to -$293.3 million in 2022, then surged by 55.76% to -$129.8 million in 2023, then plummeted by 49.93% to -$194.6 million in 2024, then skyrocketed by 47.87% to -$101.4 million in 2025.
- Business Quant data shows Enterprise Value for CLOV at -$101.4 million in Q4 2025, -$191.9 million in Q3 2025, and -$190.4 million in Q2 2025.